Tradestie Institutional Equity Comparison Engine

MCHPP vs AMBQ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMBQ Overall Edge

AMBQ Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ambiq Micro, Inc. (AMBQ) driven by superior Momentum & Technical, Options & Structure while MCHPP counters with relative strength in Growth & Margin. Fundamentally, MCHPP trades at N/M Forward P/E with 21.6% operating margin (+42.2% YoY revenue) versus AMBQ at N/M Forward P/E and -36.0% operating margin (+110.0% YoY). In options structure, MCHPP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AMBQ sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MCHPP N/M vs AMBQ N/M Fwd P/E
Growth & Margin Winner MCHPP
Op Margin 21.6% vs -36.0% ยท YoY +42.2% vs +110.0%
Momentum & Technical Winner AMBQ
1Y +0.2% vs +70.3% ยท 52W Pos 13% vs 32%
Options & Structure Winner AMBQ
UNCLASSIFIED (N/A IV) vs BREAKDOWN (27th %ile IV)
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.35
-3.72% 1D
Market Cap N/A
1M Return -17.87%
1Y Return +0.25%
Forward P/E N/M
Unified AI Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
AMBQ NYSE
Ambiq Micro, Inc.
Semiconductors & Related Devices
$44.06
-7.16% 1D
Market Cap $1.2B
1M Return -11.67%
1Y Return +70.31%
Forward P/E N/M
Unified AI Score
46.9 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 65.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MCHPP +0.25% AMBQ +70.31% Spread: +70.06 pp (AMBQ Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MCHPP TTM Op. Margin: 21.6% AMBQ TTM Op. Margin: -36.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCHPP vs AMBQ. Trailing 12-month operating profitability (MCHPP 21.6% vs AMBQ -36.0%) and valuation multiples (MCHPP N/M vs AMBQ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MCHPP (5) vs AMBQ (3)
Institutional Metric MCHPP AMBQ Criterion Row Winner
Market Capitalization Scale N/A $1.2B Larger Scale AMBQ
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +42.2% +110.0% Higher Growth AMBQ
Operating Margin (TTM) Profitability 21.6% -36.0% Higher Margin MCHPP
Net Profit Margin Profitability 15.0% -29.7% Higher Margin MCHPP
Return on Equity (ROE) Capital Efficiency 12.6% -12.2% Higher ROE MCHPP
52-Week Range Position Momentum 13% ($47โ€“$88) 32% ($22โ€“$92) Stronger Trend AMBQ
Beta / 30D Volatility Risk Regime 2.16ฮฒ ยท 65% Vol 3.72ฮฒ ยท 125% Vol Lower Realized Risk MCHPP
Unified Institutional Score Composite Signal 57.1 / 100 (HOLD) 46.9 / 100 (HOLD) Higher Composite MCHPP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MCHPP vs AMBQ Buy Guide
MCHPP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MCHPP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AMBQ BREAKDOWN
104d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 27th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AMBQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MCHPP nor AMBQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.